# Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Canonical URL: https://biopharmsignal.com/news/VANI/vivani-medical-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update
Ticker: VANI
Company: Vivani Medical
Source: Vivani Medical
Published: 2026-03-26 20:16 EST
Original Source URL: https://investors.vivani.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-14 20:03 EST — [Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026](https://biopharmsignal.com/news/VANI/vivani-medical-to-present-at-the-emerging-growth-conference-on-july-15-2026-793033b6) — Source: Vivani Medical
- 2026-07-07 11:35 EST — [Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management](https://biopharmsignal.com/news/VANI/vivani-medical-enters-into-agreement-with-novo-nordisk-to-evaluate-npm-139-a-min-9e9275ac) — Source: Vivani Medical
- 2026-07-02 12:00 EST — [Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.](https://biopharmsignal.com/news/VANI/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cor-743c93e1) — Source: Vivani Medical
- 2026-06-26 11:30 EST — [Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker](https://biopharmsignal.com/news/VANI/vivani-medical-announces-appointment-of-august-j-moretti-to-board-of-directors-a-38ca0d85) — Source: Vivani Medical
- 2026-06-25 11:30 EST — [Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management](https://biopharmsignal.com/news/VANI/vivani-medical-receives-regulatory-approval-for-the-initiation-of-slim-1-a-phase-040f1891) — Source: Vivani Medical
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)